Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London. As one of the largest independent clinical research organisations in the UK, Richmond Pharmacology has the expertise and equipment to adapt its London Bridge facility to administer vaccines for many residents in Southwark and the surrounding areas.  


Neil Coyle MP for Southwark and Old Borough outlines why this is important in his interview with BBC Politics London.


Richmond Pharmacology has been supporting the local community throughout the pandemic by providing rapid COVID tests to a local primary school, church, and synagogue. Assistance was also offered to staff at nearby businesses and hospitals when testing for the virus was not easily accessible.


Keith Berelowitz, Director of Operations at Richmond Pharmacology, said: “At what could be a pivotal moment during this pandemic, we must all do what we can to expedite the rollout of the vaccine in our local communities. We recognise that Richmond Pharmacology has the skills and facilities to support the Government in ensuring that the most vulnerable in our society are protected as soon as possible.”


Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event